Kwan Y. Wong

Pokfulam Road, Pokfulam
Hong Kong, HCW, Hong Kong Special Administrative Region

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

A proof-of-concept study for the pathogenetic role of enhancer hypomethylation of MYBPHL in multiple myeloma.

A proof-of-concept study for the pathogenetic role of enhancer hypomethylation of MYBPHL in multiple myeloma.

Journal: Scientific reports
Published: August 13, 2020

Venetoclax, bortezomib and S63845, an MCL1 inhibitor, in multiple myeloma.

Venetoclax, bortezomib and S63845, an MCL1 inhibitor, in multiple myeloma.

Journal: The Journal of pharmacy and pharmacology
Published: August 18, 2019

Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact.

Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact.

Journal: Clinical epigenetics
Published: November 29, 2018

Frequent functional activation of RAS signalling not explained by RAS/RAF mutations in relapsed/refractory multiple myeloma.

Frequent functional activation of RAS signalling not explained by RAS/RAF mutations in relapsed/refractory multiple myeloma.

Journal: Scientific reports
Published: June 25, 2018

Epigenetic silencing of EVL/miR-342 in multiple myeloma.

Epigenetic silencing of EVL/miR-342 in multiple myeloma.

Journal: Translational research : the journal of laboratory and clinical medicine
Published: October 10, 2017

Epigenetic silencing of LPP/miR-28 in multiple myeloma.

Epigenetic silencing of LPP/miR-28 in multiple myeloma.

Journal: Journal of clinical pathology
Published: April 06, 2017

High applicability of ASO-RQPCR for detection of minimal residual disease in multiple myeloma by entirely patient-specific primers/probes.

High applicability of ASO-RQPCR for detection of minimal residual disease in multiple myeloma by entirely patient-specific primers/probes.

Journal: Journal of hematology & oncology
Published: September 03, 2016

Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia.

Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia.

Journal: Oncotarget
Published: January 20, 2016

DNA methylation of tumor suppressor protein-coding and non-coding genes in multiple myeloma.

DNA methylation of tumor suppressor protein-coding and non-coding genes in multiple myeloma.

Journal: Epigenomics
Published: September 30, 2015

Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD/ERK and PIK3R2/AKT signaling pathways.

Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD/ERK and PIK3R2/AKT signaling pathways.

Journal: Oncotarget
Published: August 16, 2015

Epigenetic silencing of a long non-coding RNA KIAA0495 in multiple myeloma.

Epigenetic silencing of a long non-coding RNA KIAA0495 in multiple myeloma.

Journal: Molecular cancer
Published: June 08, 2015

Infrequent DNA methylation of miR-9-1 and miR-9-3 in multiple myeloma.

Infrequent DNA methylation of miR-9-1 and miR-9-3 in multiple myeloma.

Journal: Journal of clinical pathology
Published: December 11, 2014
Showing 1-12 of 18

Last Updated: 09/26/2026